Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
Open Access
- 1 January 2014
- journal article
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 12 (1) , 21
Abstract
In hepatocellular carcinoma (HCC), different signaling pathways are de-regulated, and among them, the expression of the epidermal growth factor receptor (EGFR). Tyrphostin AG-1478 is a lipophilic low molecular weight inhibitor of EGFR, preferentially acting on liver tumor cells. In order to overcome its poor drug solubility and thus improving its anticancer activity, it was entrapped into nanostructured lipid carriers (NLC) by using safe ingredients for parenteral delivery.Keywords
This publication has 19 references indexed in Scilit:
- Lipid Nanocarriers Containing Ester Prodrugs of Flurbiprofen Preparation, Physical-Chemical Characterization and Biological StudiesJournal of Biomedical Nanotechnology, 2013
- The tyrphostin AG1478 inhibits proliferation and induces death of liver tumor cells through EGF receptor-dependent and independent mechanismsBiochemical Pharmacology, 2011
- Phospholipid–polyaspartamide micelles for pulmonary delivery of corticosteroidsInternational Journal of Pharmaceutics, 2011
- Nanoparticle-based targeted drug deliveryExperimental and Molecular Pathology, 2009
- Nanostructured Lipid Carriers-Containing Anticancer Compounds: Preparation, Characterization, and Cytotoxicity StudiesDrug Delivery, 2007
- COX-2 Expression in Hepatocellular Carcinoma is an Initiation Event; While EGF Receptor Expression with Downstream Pathway Activation is a Prognostic Predictor of SurvivalAnnals of Surgical Oncology, 2006
- Parameters influencing the stealthiness of colloidal drug delivery systemsBiomaterials, 2006
- Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinaseBiochemical Pharmacology, 2006
- EGFR is phosphorylated at Ty845 in hepatocellular carcinomaLaboratory Investigation, 2006
- Induction of plasma protein secretion in a newly established human hepatoma cell line.Molecular and Cellular Biology, 1983